Aim immunotech completes and closes atm facility; current capital expected to meet needs for current clinical trials

Ocala, fla., feb. 05, 2021 (globe newswire) -- aim immunotech inc. (nyse american: aim) today announced that it has completed its at-the-market (atm) facility and closed the atm's equity distribution agreement (eda). management believes, based on the company's current financial condition, that it has adequate funds to meet its anticipated operational cash needs and fund current clinical trials over approximately the next twenty-four months.
AIM Ratings Summary
AIM Quant Ranking